Acute tumor lysis syndrome secondary to hydroxycarbamide in chronic myelomonocytic leukemia.
Zaher K
ZK
Otrock
Ali T
AT
Taher
Rami A R
RA
Mahfouz
Jawad A
JA
Makarem
Ali I
AI
Shamseddine
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage / Q000009:adverse effects*; D015477:Leukemia, Myelomonocytic, Chronic / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D015275:Tumor Lysis Syndrome / Q000209:etiology* / Q000628:therapy
D000970:Antineoplastic Agents; D006918:Hydroxyurea